| MeSH term | MeSH ID | Detail |
|---|---|---|
| Hemolysis | D006461 | 131 associated lipids |
| Uremia | D014511 | 33 associated lipids |
| Colitis, Ulcerative | D003093 | 24 associated lipids |
| Stomach Ulcer | D013276 | 75 associated lipids |
| Kidney Failure, Chronic | D007676 | 51 associated lipids |
| Nocardia Infections | D009617 | 6 associated lipids |
| Diarrhea | D003967 | 32 associated lipids |
| Diabetes Mellitus | D003920 | 90 associated lipids |
| Graft Occlusion, Vascular | D006083 | 11 associated lipids |
| Hypercalcemia | D006934 | 13 associated lipids |
| Neovascularization, Pathologic | D009389 | 39 associated lipids |
| Adenocarcinoma | D000230 | 166 associated lipids |
| Dermatitis, Contact | D003877 | 59 associated lipids |
| Bacterial Infections | D001424 | 21 associated lipids |
| Pain | D010146 | 64 associated lipids |
| Autoimmune Diseases | D001327 | 27 associated lipids |
| Lupus Erythematosus, Systemic | D008180 | 43 associated lipids |
| Genital Diseases, Female | D005831 | 7 associated lipids |
| Mouth Diseases | D009059 | 5 associated lipids |
| Meningococcal Infections | D008589 | 3 associated lipids |
tacrolimus
Tacrolimus is a lipid of Polyketides (PK) class. Tacrolimus is associated with abnormalities such as Renal glomerular disease. The involved functions are known as inhibitors, Fungicidal activity, Metabolic Inhibition, Excretory function and Dephosphorylation. Tacrolimus often locates in Hepatic, Mitochondrial matrix and Inner mitochondrial membrane. The associated genes with Tacrolimus are RHOA gene and BGN gene.
Cross Reference
Introduction
To understand associated biological information of tacrolimus, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.
What diseases are associated with tacrolimus?
tacrolimus is suspected in Renal glomerular disease, Candidiasis, Mycoses, PARKINSON DISEASE, LATE-ONSET, Morphologically altered structure, Skin Diseases, Infectious and other diseases in descending order of the highest number of associated sentences.
Related references are mostly published in these journals:
- Antimicrob. Agents Chemother. (2)
- Am. J. Physiol. Renal Physiol. (1)
- Drug Metab. Dispos. (1)
- Others (1)
| Disease | Cross reference | Weighted score | Related literature |
|---|
Loading... please refresh the page if content is not showing up.
Possible diseases from mapped MeSH terms on references
We collected disease MeSH terms mapped to the references associated with tacrolimus
PubChem Associated disorders and diseases
What pathways are associated with tacrolimus
There are no associated biomedical information in the current reference collection.
PubChem Biomolecular Interactions and Pathways
Link to PubChem Biomolecular Interactions and PathwaysWhat cellular locations are associated with tacrolimus?
Visualization in cellular structure
Associated locations are in red color. Not associated locations are in black.
Related references are published most in these journals:
| Location | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What functions are associated with tacrolimus?
Related references are published most in these journals:
| Function | Cross reference | Weighted score | Related literatures |
|---|
What lipids are associated with tacrolimus?
Related references are published most in these journals:
| Lipid concept | Cross reference | Weighted score | Related literatures |
|---|
Loading... please refresh the page if content is not showing up.
What genes are associated with tacrolimus?
Related references are published most in these journals:
| Gene | Cross reference | Weighted score | Related literatures |
|---|
What common seen animal models are associated with tacrolimus?
There are no associated biomedical information in the current reference collection.
NCBI Entrez Crosslinks
All references with tacrolimus
Download all related citations| Authors | Title | Published | Journal | PubMed Link |
|---|---|---|---|---|
| Fegan A et al. | Chemically controlled protein assembly: techniques and applications. | 2010 | Chem. Rev. | pmid:20353181 |
| Miyazaki I et al. | On-chip fragment-based approach for discovery of high-affinity bivalent inhibitors. | 2009 | Chembiochem | pmid:19226504 |
| Zlotkowski K et al. | Small-molecule mechanism of action studies in Caenorhabditis elegans. | 2013 | Chembiochem | pmid:24123757 |
| Yapici E et al. | An adaptable luminescence resonance energy transfer assay for measuring and screening protein-protein interactions and their inhibition. | 2012 | Chembiochem | pmid:22271654 |
| Bis DM et al. | Characterization of the nocardiopsin biosynthetic gene cluster reveals similarities to and differences from the rapamycin and FK-506 pathways. | 2015 | Chembiochem | pmid:25755076 |
| Kozany C et al. | Fluorescent probes to characterise FK506-binding proteins. | 2009 | Chembiochem | pmid:19418507 |
| Lin YH and Pratt MR | A dual small-molecule rheostat for precise control of protein concentration in Mammalian cells. | 2014 | Chembiochem | pmid:24615791 |
| Raju R et al. | Nocardiopsins: new FKBP12-binding macrolide polyketides from an Australian marine-derived actinomycete, Nocardiopsis sp. | 2010 | Chemistry | pmid:20112311 |
| Risseeuw MD et al. | A "clickable" MTX reagent as a practical tool for profiling small-molecule-intracellular target interactions via MASPIT. | 2013 | ChemMedChem | pmid:23341183 |
| Allison JR and van Gunsteren WF | A method to explore protein side chain conformational variability using experimental data. | 2009 | Chemphyschem | pmid:19882615 |
| Ross DJ et al. | FK 506 'rescue' immunosuppression for obliterative bronchiolitis after lung transplantation. | 1997 | Chest | pmid:9367453 |
| Koga T et al. | Pulmonary infiltrates recovered by FK506 in a patient with Behçet's disease. | 1993 | Chest | pmid:7686837 |
| Kyaw TH et al. | A 45-Year-Old Woman With 3 Weeks of Cough and Night Sweats. | 2016 | Chest | pmid:26965979 |
| Serrano-Mollar A et al. | Safety and Tolerability of Alveolar Type II Cell Transplantation in Idiopathic Pulmonary Fibrosis. | 2016 | Chest | pmid:27020420 |
| FDA warns about Elidel, Protopic. | 2005 | Child Health Alert | pmid:16130225 | |
| Wu MF et al. | Combination Therapy of Tacrolimus and Chinese Herb Medicated Bath in Children with Inverse Psoriasis. | 2018 | Chin J Integr Med | pmid:28914435 |
| Lucchina S et al. | FK-506 ointment: an effective adjuvant therapy to treat a dramatic case of pyoderma gangrenosum of unilateral hand. | 2009 | Chin. J. Traumatol. | pmid:19486563 |
| Liao JH et al. | Gene Variations of Sixth Complement Component Affecting Tacrolimus Metabolism in Patients with Liver Transplantation for Hepatocellular Carcinoma. | 2017 | Chin. Med. J. | pmid:28685716 |
| An Q et al. | High Colonization and Impaired Permeability Barrier in Facial Seborrheic Dermatitis. | 2017 | Chin. Med. J. | pmid:28685715 |
| Wang J et al. | Molecular mechanisms of FK506-induced hypertension in solid organ transplantation patients. | 2014 | Chin. Med. J. | pmid:25316243 |
| Liu T et al. | Tacrolimus-related hypertrophic cardiomyopathy in an adult cardiac transplant patient. | 2012 | Chin. Med. J. | pmid:22613615 |
| Xue W et al. | Effects of tacrolimus and cyclosporine treatment on metabolic syndrome and cardiovascular risk factors after renal transplantation: a meta-analysis. | 2014 | Chin. Med. J. | pmid:24931259 |
| Raja SG | Drug-eluting stents: is it the beginning of the end for coronary artery bypass surgery? | 2004 | Chin. Med. J. | pmid:15377432 |
| Huang H et al. | Effect and mechanism of tacrolimus on melanogenesis on A375 human melanoma cells. | 2014 | Chin. Med. J. | pmid:25131236 |
| Chen QQ et al. | Kaposi's Varicelliform Eruption During Long-term Treatment of Rosacea with 0.03% Tacrolimus Ointment. | 2015 | Chin. Med. J. | pmid:26481759 |
| Ding CG et al. | Early Immunosuppressive Exposure of Enteric-Coated-Mycophenolate Sodium Plus Tacrolimus Associated with Acute Rejection in Expanded Criteria Donor Kidney Transplantation. | 2018 | Chin. Med. J. | pmid:29786042 |
| Wang JY and Fan H | P70S6 kinase phosphorylation: a new site to assess pharmacodynamy of sirolimus. | 2015 | Chin. Med. J. | pmid:25698201 |
| Han YL et al. | Midterm outcomes of prospective, randomized, single-center study of the Janus tacrolimus-eluting stent for treatment of native coronary artery lesions. | 2007 | Chin. Med. J. | pmid:17442201 |
| Li H et al. | Symptomatic osteonecrosis of the femoral head after adult orthotopic liver transplantation. | 2012 | Chin. Med. J. | pmid:22882914 |
| Zhu QG et al. | Two-year observation of a randomized trial on tacrolimus-based therapy with withdrawal of steroids or mycophenolate mofetil after renal transplantation. | 2008 | Chin. Med. Sci. J. | pmid:19180887 |
| Guo CL et al. | Efficacy of Topical Tacrolimus for Erosive Oral Lichen Planus: A Meta-analysis. | 2015 | Chin. Med. Sci. J. | pmid:26960301 |
| Herzberg G et al. | Clinical evaluation of two bilateral hand allotransplantations at six and three years follow-up. | 2008 Apr-Jun | Chir Main | pmid:18407777 |
| Kohlhaw K et al. | [Clinical studies in liver transplantation]. | 2000 | Chirurg | pmid:10948733 |
| Bachinger A et al. | [Immunosuppression with tacrolimus (FK 506) and cyclosporin A for preventing graft rejection after liver transplantation. Retrospective evaluation of medical costs based on the FG-O157 Study in 224 patients (Germany)]. | 1998 | Chirurg | pmid:9816454 |
| Al Ghazal P and Dissemond J | [Multilocular pyoderma gangrenosum after uterus resection]. | 2012 | Chirurg | pmid:22290226 |
| Dubernard JM et al. | [The first transplantation of a hand in humans. Early results]. | 1999 | Chirurgie | pmid:10546388 |
| Bitker MO et al. | [Combined renal and pancreas transplantation as treatment for chronic renal insufficiency of diabetic origin: a series of 50 consecutive transplantations]. | 1999 | Chirurgie | pmid:10615774 |
| Crétolle-Vastel C et al. | [Role of calcineurin-dependent drugs on the immunosuppressive effect induced by the anti-LFA-1 antibody in a fetal intestinal transplantation model in mice]. | 1999 | Chirurgie | pmid:10615777 |
| Balibrea del Castillo JM et al. | [Cytoprotective effect of low-dose tacrolimus on islets of Langerhans in cultures subjected to stimulation by acute rejection cytokines]. | 2010 | Cir Esp | pmid:20452578 |
| Baran DA et al. | A prospective, randomized trial of single-drug versus dual-drug immunosuppression in heart transplantation: the tacrolimus in combination, tacrolimus alone compared (TICTAC) trial. | 2011 | Circ Heart Fail | pmid:21216835 |
| Kobashigawa JA | Strategies in immunosuppression after heart transplantation: is less better? | 2011 | Circ Heart Fail | pmid:21406677 |
| Wada K et al. | Limited sampling strategy for mycophenolic acid in Japanese heart transplant recipients: comparison of cyclosporin and tacrolimus treatment. | 2007 | Circ. J. | pmid:17587705 |
| Hotta H et al. | Angiotensin II type 1 receptor-mediated upregulation of calcineurin activity underlies impairment of cardioprotective signaling in diabetic hearts. | 2010 | Circ. Res. | pmid:19910577 |
| Marx SO et al. | Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. | 1995 | Circ. Res. | pmid:7532117 |
| Zhang W et al. | Failure of calcineurin inhibitors to prevent pressure-overload left ventricular hypertrophy in rats. | 1999 | Circ. Res. | pmid:10189360 |
| Turner MS et al. | Reversible connexin 43 dephosphorylation during hypoxia and reoxygenation is linked to cellular ATP levels. | 2004 | Circ. Res. | pmid:15358666 |
| Qi XY et al. | Cellular signaling underlying atrial tachycardia remodeling of L-type calcium current. | 2008 | Circ. Res. | pmid:18723446 |
| Lyson T et al. | Cyclosporine- and FK506-induced sympathetic activation correlates with calcineurin-mediated inhibition of T-cell signaling. | 1993 | Circ. Res. | pmid:7688670 |
| McCall E et al. | Effects of FK-506 on contraction and Ca2+ transients in rat cardiac myocytes. | 1996 | Circ. Res. | pmid:8943949 |
| Molkentin JD | Calcineurin and beyond: cardiac hypertrophic signaling. | 2000 | Circ. Res. | pmid:11055975 |
| Prestle J et al. | Overexpression of FK506-binding protein FKBP12.6 in cardiomyocytes reduces ryanodine receptor-mediated Ca(2+) leak from the sarcoplasmic reticulum and increases contractility. | 2001 | Circ. Res. | pmid:11157671 |
| Gammie JS et al. | Tacrolimus-based partial conditioning produces stable mixed lymphohematopoietic chimerism and tolerance for cardiac allografts. | 1998 | Circulation | pmid:9852899 |
| Sun J et al. | Role for p27(Kip1) in Vascular Smooth Muscle Cell Migration. | 2001 | Circulation | pmid:11413088 |
| Daemen J and Serruys PW | Drug-eluting stent update 2007: part II: Unsettled issues. | 2007 | Circulation | pmid:17709651 |
| Dorn GW | Calcineurin inhibition in hypertrophy: back from the dead! | 2001 | Circulation | pmid:11435329 |
| Yano M et al. | FKBP12.6-mediated stabilization of calcium-release channel (ryanodine receptor) as a novel therapeutic strategy against heart failure. | 2003 | Circulation | pmid:12551874 |
| Shimoyama M et al. | Calcineurin plays a critical role in pressure overload-induced cardiac hypertrophy. | 1999 | Circulation | pmid:10595959 |
| Yano M et al. | Altered stoichiometry of FKBP12.6 versus ryanodine receptor as a cause of abnormal Ca(2+) leak through ryanodine receptor in heart failure. | 2000 | Circulation | pmid:11044432 |
| Fröhlich GM et al. | Statins and the risk of cancer after heart transplantation. | 2012 | Circulation | pmid:22761452 |
| Steffel J et al. | Rapamycin, but not FK-506, increases endothelial tissue factor expression: implications for drug-eluting stent design. | 2005 | Circulation | pmid:16172265 |
| Marx SO and Marks AR | Bench to bedside: the development of rapamycin and its application to stent restenosis. | 2001 | Circulation | pmid:11514367 |
| Lindenfeld J et al. | Drug therapy in the heart transplant recipient: part II: immunosuppressive drugs. | 2004 | Circulation | pmid:15611389 |
| Van Driest SL and Webber SA | Pharmacogenomics: personalizing pediatric heart transplantation. | 2015 | Circulation | pmid:25645611 |
| Hausberg M et al. | Sympathetic nerve activity in end-stage renal disease. | 2002 | Circulation | pmid:12370222 |
| Takeda Y et al. | Calcineurin inhibition attenuates mineralocorticoid-induced cardiac hypertrophy. | 2002 | Circulation | pmid:11839620 |
| Sakata Y et al. | Calcineurin inhibitor attenuates left ventricular hypertrophy, leading to prevention of heart failure in hypertensive rats. | 2000 | Circulation | pmid:11056104 |
| Tokudome T et al. | Calcineurin-nuclear factor of activated T cells pathway-dependent cardiac remodeling in mice deficient in guanylyl cyclase A, a receptor for atrial and brain natriuretic peptides. | 2005 | Circulation | pmid:15939815 |
| Ortolani P et al. | Two-year clinical outcomes with drug-eluting stents for diabetic patients with de novo coronary lesions: results from a real-world multicenter registry. | 2008 | Circulation | pmid:18250265 |
| Doi M et al. | Propranolol prevents the development of heart failure by restoring FKBP12.6-mediated stabilization of ryanodine receptor. | 2002 | Circulation | pmid:11901051 |
| Shimoyama M et al. | Calcineurin inhibitor attenuates the development and induces the regression of cardiac hypertrophy in rats with salt-sensitive hypertension. | 2000 | Circulation | pmid:11034951 |
| Jordan ML et al. | Initial studies with FK506 in renal transplantation. | 1991 Sep-Oct | Cleve Clin J Med | pmid:1718631 |
| Sbenghe MM et al. | Chronic myeloid leukemia following heart transplantation and immunosuppression with tacrolimus. | 2011 | Clin Adv Hematol Oncol | pmid:22236991 |
| Yukawa N and Mimori T | [Effect of disease modifying anti-rheumatic drugs on radiographic progression in rheumatoid arthritis]. | 2009 | Clin Calcium | pmid:19252250 |
| Tanaka Y et al. | [Efficacy of tacrolimus for joint destruction in rheumatoid arthritis]. | 2007 | Clin Calcium | pmid:17404490 |
| Ichikawa N and Yamanaka H | [ Bone and cartilage destruction in RA and its intervention. Disease-modifying antirheumatic drugs]. | 2012 | Clin Calcium | pmid:22298075 |
| Nakagawa H | Comparison of the efficacy and safety of 0.1% tacrolimus ointment with topical corticosteroids in adult patients with atopic dermatitis: review of randomised, double-blind clinical studies conducted in Japan. | 2006 | Clin Drug Investig | pmid:17163257 |
| Bifano M et al. | An open-label investigation into drug-drug interactions between multiple doses of daclatasvir and single-dose cyclosporine or tacrolimus in healthy subjects. | 2015 | Clin Drug Investig | pmid:25896946 |
| Lancia P et al. | Adverse Events under Tacrolimus and Cyclosporine in the First 3 Years Post-Renal Transplantation in Children. | 2018 | Clin Drug Investig | pmid:29236209 |
| Miura M et al. | Influence of cytochrome P450 (CYP) 3A5 polymorphisms on the pharmacokinetics of lansoprazole enantiomers in CYP2C19 extensive metaboliser renal transplant recipients. | 2007 | Clin Drug Investig | pmid:17358097 |
| Bergmann TK et al. | Comparison of the influence of cyclosporine and tacrolimus on the pharmacokinetics of prednisolone in adult male kidney transplant recipients. | 2014 | Clin Drug Investig | pmid:24385281 |
| Grobecker HF et al. | Cyclosporine A-induced hypertension in SHR and WKY: role of the sympatho-adrenal system. | 1995 | Clin Exp Pharmacol Physiol Suppl | pmid:9072458 |
| Kinoshita T et al. | Diffusion-weighted MR imaging of posterior reversible leukoencephalopathy syndrome: a pictorial essay. | 2003 Sep-Oct | Clin Imaging | pmid:12932680 |
| Zhu Y et al. | FK506 treatment in a Long-term chronic rejection rat model of small bowel transplantation. | 2010 | Clin Invest Med | pmid:20519095 |
| Zhu Y and Zhou J | Increased NPC1L1 and serum cholesterol in a chronic rejection rat. | 2011 | Clin Invest Med | pmid:21631994 |
| Tremblay JP | CSCI/RCPSC Henry Friesen Lecture: Cell therapy for Duchenne muscular dystrophy. | 2006 | Clin Invest Med | pmid:17330454 |
| Cox KL and Freese DK | Tacrolimus (FK506): the pros and cons of its use as an immunosuppressant in pediatric liver transplantation. | 1996 | Clin Invest Med | pmid:8889279 |
| Menéndez Valladares P et al. | [Increased lipoprotein(a) in a paediatric patient associated with nephrotic syndrome]. | Clin Investig Arterioscler | pmid:27623226 | |
| Gaston RS | Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm. | 2009 | Clin J Am Soc Nephrol | pmid:19850771 |
| Burroughs TE et al. | Influence of early posttransplantation prednisone and calcineurin inhibitor dosages on the incidence of new-onset diabetes. | 2007 | Clin J Am Soc Nephrol | pmid:17699459 |
| Wiseman AC | Induction Therapy in Renal Transplantation: Why? What Agent? What Dose? We May Never Know. | 2015 | Clin J Am Soc Nephrol | pmid:25979977 |
| Tanriover B et al. | Induction Therapies in Live Donor Kidney Transplantation on Tacrolimus and Mycophenolate With or Without Steroid Maintenance. | 2015 | Clin J Am Soc Nephrol | pmid:25979971 |
| Fioretto P et al. | Tacrolimus and cyclosporine nephrotoxicity in native kidneys of pancreas transplant recipients. | 2011 | Clin J Am Soc Nephrol | pmid:21051744 |
| de Winter BC et al. | Nonlinear relationship between mycophenolate mofetil dose and mycophenolic acid exposure: implications for therapeutic drug monitoring. | 2011 | Clin J Am Soc Nephrol | pmid:21088289 |
| De Rycke A et al. | Tacrolimus-induced neutropenia in renal transplant recipients. | 2011 | Clin J Am Soc Nephrol | pmid:21258040 |
| Tanriover B et al. | Acute Rejection Rates and Graft Outcomes According to Induction Regimen among Recipients of Kidneys from Deceased Donors Treated with Tacrolimus and Mycophenolate. | 2016 | Clin J Am Soc Nephrol | pmid:27364616 |
| Gelens MA et al. | Immunosuppressive regimen and interstitial fibrosis and tubules atrophy at 12 months postrenal transplant. | 2012 | Clin J Am Soc Nephrol | pmid:22490875 |
| Kiberd B and Panek R | Cardiovascular outcomes in the outpatient kidney transplant clinic: the Framingham risk score revisited. | 2008 | Clin J Am Soc Nephrol | pmid:18322053 |
| Naesens M et al. | Calcineurin inhibitor nephrotoxicity. | 2009 | Clin J Am Soc Nephrol | pmid:19218475 |
| Taber DJ et al. | A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant Recipients. | 2017 | Clin J Am Soc Nephrol | pmid:27979979 |
| Bramham K et al. | Breastfeeding and tacrolimus: serial monitoring in breast-fed and bottle-fed infants. | 2013 | Clin J Am Soc Nephrol | pmid:23349333 |